Impact of smoking status on the biological behavior of lung cancer

Surgery Today

Volumn 37, Issue 9, 2007, Pages 725-734

  Yoshino, Ichiro ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Benzo(a)pyrene; FHIT; Hexokinase; Hypoxia inducible factor; Loss of heterozygosity; Lung cancer; Methylation; Polycyclic aromatic hydrocarbon; Tobacco smoking

Indexed keywords

ANTINEOPLASTIC AGENT; BENZO[A]PYRENE; POLYCYCLIC AROMATIC HYDROCARBON; QUERCETIN; SELENIUM; TOBACCO SMOKE;

ANTINEOPLASTIC ACTIVITY; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURGERY; CELL DIVISION; CELL PROLIFERATION; CLINICAL TRIAL; CYTOSTASIS; DNA DAMAGE; DRUG MECHANISM; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SURGERY; NUCLEIC ACID METABOLISM; ONCOGENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TREATMENT OUTCOME; TUMOR IMMUNITY;

ACID ANHYDRIDE HYDROLASES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BENZO(A)PYRENE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HEALTH BEHAVIOR; HEALTH STATUS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; JAPAN; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; METHYLATION; NEOPLASM PROTEINS; PROGNOSIS; RISK FACTORS; SMOKING; TOBACCO;

EID: 34548164081     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3516-6     Document Type: Review

References (90)

1. WA Pryor K Stone 1993 Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite Ann N Y Acad Sci 686 12 27
2. GP Pfeifer MF Denissenko M Olivier N Tretyakova SS Hecht P Hainaut 2002 Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers Oncogene 21 7435 51
3. PA Wingo T Tong S Bolden 1995 Cancer statistics, 1995 CA Cancer J Clin 45 8 30
4. AJ Farkas EA Gilpin JM Distefan JP Pierce 1999 The effect of household and workplace smoking restrictions on quitting behaviours Tobacco Control 8 261 5
5. Food and Agriculture Organization of the United States (FAO). FaoStat Statistical databases. http://www.apps.fao.org/
6. MS Jaakkola JJ Jaakkola 1997 Assessment of exposure to environmental tobacco smoke Eur Respir J 10 2384 97
7. A Johnson-Early MH Cohen JD Minna LM Paxton BE Fossieck Jr DC Ihde 1980 Smoking abstinence and small cell lung cancer survival: an association JAMA 244 2175 9
8. GMM Videtic LW Stitt R Dar WI Kocha AT Tomiak PT Truong 2003 Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival J Clin Oncol 21 1544 9
9. CM Tammemagi C Neslund-Dudas M Simoff P Kvale 2004 Smoking and lung cancer survival: the role of comorbidity and treatment Chest 125 27 37
10. C-K Toh E-H Wong W-T Lim S-S Leong K-W Fong J Wee 2004 The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer. A retrospective analysis Chest 126 1750 6
11. I Yoshino H Baba F Fukuyama T Kameyama Y Shikada M Tomiyasu 2002 A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer Surgery 131 S226 31
12. AS Tsao D Liu JJ Lee M Spitz WK Hong 2006 Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer Cancer 106 2428 36
13. LT Nordquist GR Simon A Canter M Alberts G Bepler 2004 Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung Chest 126 347 51
14. D Rice HW Kim A Sabichi S Lippman JJ Lee B Williams 2003 The risk of second primary lung tumors after resection of stage I nonsmall cell lung cancer Ann Thorac Surg 76 1001 7 discussion, 1007-8
15. Y-C Wu C-F J Lin W-H Hsu B-S Huang M-H Huang L-S Wang 2003 Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control Eur J Cardiothorac Surg 24 994 1001
16. I Yoshino D Kawano T Oba K Yamazaki T Kometani 2006 Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma Ann Thorac Surg 81 1189 93
17. I Yoshino A Osoegawa T Yohena T Kameyama E Oki S Oda 2005 Loss of heterozygosity in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma Resp Med 99 308 12
18. I Yoshino S Fukuyama T Kameyama H Baba Y Shikada R Suemitsu 2003 Detection of loss of heterozygosity by high-resolution fluorescent system in non-small cell lung cancer: association of loss of heterozygosity with smoking and tumor progression Chest 123 545 50
19. L Mao JS Lee JM Kurie YH Fan SM Lippman JJ Lee 1997 Clonal genetic alterations in the lungs of current and former smokers J Natl Cancer Inst 89 857 62
20. G Sozzi L Sard L De Gregorio A Marchetti K Musso F Buttitta 1997 Association between cigarette smoking and FHIT gene alterations in lung cancer Cancer Res 57 2121 3
21. JS Kim H Kim YM Shim J Han J Park DH Kim 2004 Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung Carcinogenesis 25 2165 71
22. R Maruyama K Sugio I Yoshino Y Maehara AF Gazdar 2004 Hypermethylation of the FHIT as a prognostic marker in nonsmall cell lung cancer Cancer 100 1472 7
23. Y Daigaku K Endo E Watanabe T Ono K Yamamoto 2004 Loss of heterozygosity and DNA damage repair in Saccharomyces cervisiae Mutat Res 22 183 91
24. IYS Tam LP Chung WS Suen E Wang MCM Wong KK Ho 2006 Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features Clin Cancer Res 12 1647 53
25. GP Pfifer P Hainaut 2003 On the origin of G → T transversions in lung cancer Mutat Res 526 39 43
26. Y Fukuyama T Mitsudomi K Sugio T Ishida K Akazawa K Sugimachi 1997 K-ras and p53 mutations are an independent unfavorable prognostic indicators in patients with non-small cell lung cancer Br J Cancer 78 1125 30
27. N Hagiwara LE Mechanic GE Trivers HL Cawley M Taga ED Bowman 2006 Quantitative detection of p53 mutations in plasma DNA from tobacco smokers Cancer Res 66 8309 17
28. T Winton R Livingston D Johnson J Rigas M Johnston C Butts 2005 National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2589 97
29. F Le Calvez A Mukeria JD Hunt O Kelm RJ Hung P Taniere 2005 TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers Cancer Res 65 5076 83
30. TM Greatens GA Niehans JB Rubins J Jessurun RA Kratzke MA Maddaus 1998 Do molecular markers predict survival in non-small-cell lung cancer? Am J Resp Crit Med 157 1093 7
31. R Ahuja SB Weibel FT Leone 2003 Lung cancer: the oncologist's role in smoking cessation Sem Oncol 30 94 103
32. MT Halpen BW Gillespi KE Warner 1993 Patterns of absolute risk of lung cancer mortality in former smokers J Natl Cancer Inst 85 457 64
33. Z Zhang J Ma N Sun C Wang 2006 Expression of nuclear factor-kappa V and its clinical significance in nonsmall-cell lung cancer Ann Thorac Surg 82 243 8
34. M Pagano S Tam A Theodoras P Beer-Romero G Del Sal V Chau 1995 Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 269 682 5
35. M Gstaiger R Jordan M Lim C Catzavelos J Mestan J Slingerland 2001 Skp2 is oncogenic and overexpressed in human cancers Proc Natl Acad Sci USA 98 5043 8
36. A Osoegawa I Yoshino S Tanaka K Sugio T Kameyama M Yamaguchi 2004 Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small cell lung cancer J Clin Oncol 22 4165 73
37. Y Shinohara J Ichihara H Terada 1991 Remarkablyenhanced expression of the type II hexokinase in rat hepatoma cell line AH130 FEBS Lett 291 55 7
38. I Yoshino T Kameyama Y Shikada T Kometani D Kawano A Osoegawa 2005 Glycolytic phenotype of non-small cell lung cancer: implication of anaerobic glycolysis on malignant potential J Clin Oncol 24s 9634
39. J Bernhagen T Calandra RA Mitchell SB Martin KJ Tracey W Voelter 1993 MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia Nature 365 756 9
40. T Calandra J Bernhagen RA Mitchell R Bucala 1994 The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor J Exp Med 179 1895 902
41. M Tomiyasu I Yoshino R Suemitsu T Okamoto K Sugimachi 2002 Quantification of MIF mRNA expression in non small cell lung cancer tissues and its clinical significance Clin Cancer Res 8 3755 60
42. Y Nakanishi XH Pei K Takayama F Bai M Izumi K Kimotsuki 2000 Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21 Am J Respir Cell Mol Biol 22 747 54
43. XH Pei Y Nakanishi H Inoue K Takayama F Bai N Hara 2002 Polycyclic aromatic hydrocarbons induce IL-8 expression through nuclear factor κB activation in A549 cell line Cytokine 19 236 41
44. DR Smith PJ Polverini SL Kunkel MB Orringer RI Whyte MD Burdick 1994 Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma J Exp Med 179 1409 15
45. MDF Askari MS Tsao HM Schuller 2005 The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through β-adrenergic transactivation of EGF receptors J Cancer Res Clin Oncol 131 639 48
46. H Lemjabbar D Li M Gallup S Sidhu E Drori C Basbaum 2003 Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor α-converting enzyme and amphiregulin J Biol Chem 278 26202 7
47. EK Chu JS Foley J Cheng AS Patel JM Drazen DJ Tschumperlin 2005 Bronchial epithelial compression regulates epidermal growth factor receptor family ligand expression in an autocrine manner Am J Respr Cell Mole Biol 32 373 80
48. C Mascaux B Martin M Paesmans T Berghmans M Dusart A Haller 2006 Has Cox-2 a prognostic factor in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results Br J Cancer 95 139 45
49. D Moraitis B Du MS De Lorenzo JO Boyle BB Weksler EG Cohen 2005 Levels of cyclooxigenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands Cancer Res 65 654 70
50. CA Martey SJ Pollock CK Turner KMA O'Reilly CJ Banglole RP Phipps 2004 Cigarette smoke induce cycooxigenase-2 and microsomal prostaglandine E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer Am J Physiol Lung Cell Mol Physiol 287 L981 91
51. M Nagayama A Sato H Hayakawa T Urano Y Takada A Takada 1994 Plasminogen activators and their inhibitors in non-small cell lung cancer Cancer 73 1398 405
52. H Pederses N Brunner D Francis K ÖSterlind E Rønne HH Hansen 1994 Prognostic impact of urokinase, urokinase receptor and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue Cancer Res 54 4671 5
53. H Rapport N Brunner 1995 The plasminogen activation system and its role in lung cancer: a review Lung Cancer 12 1 12
54. H Pederses J Grøndahl-Hansen D Francis K ÖSterlind HH Hansen E Rønne 1994 Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma Cancer Res 54 120 2
55. M Kodate T Kasai H Hashimoto K Yasumoto Y Iwata H Manabe 1997 Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung Pathol International 47 461 9
56. X-H Pei Y Nakanishi K Takayama F Bai H Hara 1999 Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor κB Activity J Biol Chem 274 35240 6
57. PG Holt D Keast 1977 Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals Bacterial Rev 41 205 16
58. P Anderson OF Pederson B Bach GJ Bonde 1982 Serum antibodies and immunoglobulins in smokers and nonsmokers Clin Exp Immunol 47 467 73
59. SM Savage LA Donaldson S Cherian R Chilukuri VA White ML Sopori 1991 Effect of cigarette smoke on the immune response: II. Chronic exposure to cigarette smoke inhibits surface immunoglobulin-mediated responses in B cells Toxicol Appl Pharmacol 111 523 9
60. AA Frazer-Abel S Baksh SP Fosmire D Willis AM Pierce H Meylemans 2004 Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells J Pharmacol Exp Ther 311 758 69
61. M Stolina S Sharma Y Lin M Dohadwala B Gardner J Luo 2000 Specific inhibition of cyclooxigenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis J Immunol 164 361 70
62. S Sharma SC Yang L Zhu K Reckamp B Gardner F Baratelli 2005 Tumor cyclooxigenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4 + CD25 + T regulatory cell activities in lung cancer Cancer Res 65 5211 20
63. I Yoshino T Yano M Murata T Ishida K Sugimachi G Kimura 1992 Tumor-reactive T cells accumulate in lung cancer tissues but fail to respond due to tumor cell -derived factor Cancer Res 52 775 81
64. R Kalra SP Singh SM Savage GL Finci ML Sopori 2000 Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca2+ stores J Pharmacol Exp Ther 293 166 71
65. CS Robbins DE Dawe SI Goncharova MA Pouladi AG Drannik FK Swirski 2004 Cigarette smoke decrease pulmonary dendritic cells and impacts antiviral immune responsiveness Am J Resp Cell Mol Biol 30 202 11
66. S Sharma M Stolina SC yang F Baratelli JF Lin K Atianzar 2003 Tumor cyclooxigenase 2-dependent suppression of dendritic cell function Clin Cancer Res 9 961 8
67. M Takenoyama I Yoshino R Eifuku S Imahayashi M Sugaya M Yasuda 2001 Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells Jpn J Cancer Res 92 309 15
68. LE Raez PA Cassileth JJ Schlesselman K Sridhar S Padmanavhan EZ Fisher 2004 Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small cell lung cancer J Clin Oncol 22 2800 7
69. D O'Mahony S Kummar ME Gutierrez 2005 Non-small-cell lung cancer vaccine therapy: a concise review J Clin Oncol 23 9022 8
70. Song N, Tan W, Xing D, Lin D. CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 1001;22:11-6
71. H Bartsch U Nair A Risch M Rojas H Wikman K Alexandrov 2000 Genetic polymorphism of CYP genes, alone and combination, as a risk modifier of tobacco-related cancers Cancer Epidemiol Biomarkers Prev 9 3 28
72. PG Shields ED Bowman AM Harrington VT Doan A Weston 1993 Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes Cancer Res 53 1381 8
73. K Alexandrov I Cascorbi M Rojas G Bouvier E Kriek H Bartsch 2002 CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation Carcinogenesis 23 1969 77
74. JP Radicella C Dherin C Desmaze MS Fox S Boiteux 1997 Cloning and characterization of hOGG1, a human homolog of OGG1 gene of Saccharomyces cerevisiae Proc Natl Acad Sci USA 94 8010 5
75. T Kohno K Shinmura M Tosaka M Tani SR Kim H Sugimura 1998 Genetic polymorphisms and alterative splicing of hOGG1, that is involved in the repair of 8-hydroxyguanine in damaged DNA Oncogene 16 3219 25
76. E Evans JG Moggs JR Hwang JM Egly RD Wood 1997 Mechanism of open complex and dual incision formation by human nucleotide excision repair factors EMBO J 16 6559 73
77. SM Hou S Falt S Angelini K Yang F Nyberg B Lambert 2002 The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk Carcinogenesis 23 599 633
78. K Hemminki M Koskinen H Rajaniemi C Zhao 2000 DNA adducts, mutations, and cancer Regul Toxicol Pharmacol 32 264 75
79. K Yang L Airoldi R Pastorelli J Restano M Guanci K Hemminiki 1996 Aromatic DNA adducts in lymphocytes of humans working at high and low traffic density areas Chemi Biol Interact 101 127 36
80. G Boysen SS Hecht 2003 Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods Mutat Res 543 17 30
81. JM Arif C Dresler ML Clapper G Gairola C Srinivason RA Lubet 2006 Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens Chem Res Toxicol 19 295 9
82. The Alpha-Tocopherol Beta-carotens Cancer Prevention Study Group 1994 The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1029 35
83. GS Omenn GE Goodman MD Thronquist J Balmes MR Cullen A Glass 1996 Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease N Engl J Med 334 1150 5
84. SM Lippman JJ Lee DD Karp EE Vokes SE Benner GE Goodman 2001 Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer J Natl Cancer Inst 93 605 18
85. MA Pereira Y Li F Al-Yazoub PM Kramer F Al-Yaqoub RA Lubet 2002 Prevention of mouse lung tumors by budesonide and its modulation of biomarkers Carcinogenesis 23 1185 92
86. RL Keith YE Miller TM Hudish CE Girod CE Girod S Sotto-Santiago 2004 Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice Cancer Res 64 5897 904
87. S Shishodia BB Aggarwal 2004 Cyclooxigenase (COX)-2 inhibitor Celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kB by suppressing activation of IkBa kinase in human non-small cell lung carcinoma: Correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9 Cancer Res 64 5004 12
88. LC Clark GF Coombs Jr BW Turnbull EH Slate DK Chalker J Chow 1996 Effects of selenium supplementation for cancer prevention in patients with carcinoma of skin JAMA 276 1957 63
89. FO Ranelletti S Maggiano FG Serra R Ricci LM Larocca P Lanza 2000 Quercetin inhibits p21-RAS expression in humancolon cancer cell lines and in primary colorectal tumors Int J Cancer 85 438 45
90. NZ Jin YP Zhu JW Zhou L Mao RC Zhao TH Fang 2006 Preventive effects of quercetin against benzo[a]pyrene induced DNA damages and pulmonary precancerous pathologic changes in mice Basic Clin Pharmacol Toxicol 98 593 8